IGF-1 LR3 Dosage Protocol | PeptideDosages.com

IGF-1 LR3 (1 mg Vial) Dosage Protocol

IGF-1 LR3 Dosage Chart

IGF-1 LR3 is dosed at 20 mcg–50 mcg daily via subcutaneous injection in educational protocols. A 1 mg vial reconstituted with bacteriostatic water yields about 0.333 mg/mL. This information is for research and educational use only.

Reconstitute: Add 3.0 mL bacteriostatic water → ~0.333 mg/mL concentration (333 mcg/mL).

Typical daily range: 20–50 mcg once daily subcutaneously (gradual titration recommended).

Easy measuring: At 0.333 mg/mL, 1 unit = 0.01 mL ≈ 3.33 mcg on a U-100 insulin syringe.

Storage: Lyophilized: freeze at −20 °C (−4 °F) for up to 12 months; after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) and use within 30 days; avoid repeated freeze–thaw cycles.

IGF-1 LR3 (Long R3 Insulin-like Growth Factor-1) is a modified analog of human IGF-1 with significantly extended half-life, studied for its anabolic and metabolic effects[1]. This synthetic variant exhibits reduced binding to IGF binding proteins, allowing enhanced bioavailability and systemic activity[2]. This educational protocol presents a once-daily subcutaneous approach with conservative titration for research applications.

Research context: For evidence on mechanisms, human and preclinical research, limitations, and safety, read IGF-1 LR3 Peptide: Benefits, Uses, Side Effects, Dosage, and Research.

Standard / Gradual Approach (3 mL = ~0.333 mg/mL)

Weeks 1–2

20 mcg (0.02 mg)

6 units (0.06 mL)

Weeks 3–4

40 mcg (0.04 mg)

12 units (0.12 mL)

Weeks 5–8

50 mcg (0.05 mg)

15 units (0.15 mL)

Frequency: Inject once daily subcutaneously, typically in the morning or post-workout with food intake to mitigate insulin-like effects on blood glucose[3]. This schedule uses the maximum practical dilution (3.0 mL) for clear measurements. For ≤10-unit (≤0.10 mL) administrations, consider 30- or 50-unit insulin syringes for improved readability.

Reconstitution Steps

Draw 3.0 mL bacteriostatic water with a sterile syringe.

Inject slowly down the vial wall to avoid foaming; do not shake.

Gently swirl or roll until the lyophilized powder dissolves completely into a clear solution.

Label the vial with reconstitution date and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.

Use within 30 days of reconstitution; for longer storage, prepare aliquots and freeze at −20 °C (−4 °F) for up to 3–6 months[4].

Supplies Needed

Plan based on an 8–16 week daily protocol with gradual titration.

Peptide Vials (IGF-1 LR3, 1 mg each):

8 weeks ≈ 3 vials (~2.24 mg total needed)

12 weeks ≈ 4 vials (~3.64 mg total needed)

16 weeks ≈ 6 vials (~5.04 mg total needed)

Insulin Syringes (U-100, 0.5 mL or 1 mL):

Per week: 7 syringes (1/day)

8 weeks: 56 syringes

12 weeks: 84 syringes

16 weeks: 112 syringes

Bacteriostatic Water (10 mL bottles): Use 3.0 mL per vial for reconstitution.

8 weeks (3 vials): 9 mL → 1 × 10 mL bottle

12 weeks (4 vials): 12 mL → 2 × 10 mL bottles

16 weeks (6 vials): 18 mL → 2 × 10 mL bottles

Alcohol Swabs: One for the vial stopper + one for the injection site each day.

Per week: 14 swabs (2/day)

8 weeks: 112 swabs → recommend 2 × 100-count boxes

12 weeks: 168 swabs → recommend 2 × 100-count boxes

16 weeks: 224 swabs → recommend 3 × 100-count boxes